Medical Devices Company Investment Opportunity in Muscat, Oman

- Oman-based new hitch innovative revolutionary startup for cancer diagnosis.

- The company has developed a Cancer Diagnostic Probe (CDP) which is designed for real-time pathology during breast cancer surgery, catering to hospitals performing such surgeries.

- The revenue model comprises both selling and renting the device, along with the sale of associated consumables.

- The client base is estimated to increase to 5,000-10,000 in the next couple of years.

- The company's device is supported by seven granted US - Patents and is backed by over 50 highly cited journal papers.

- Manufacturing is outsourced, while the design and concept is completely owned. Now planning to open own manufacturing facility as well.

- Has secured two distribution contracts this year in India and Iran, with an initial order of 1,000 devices.

- The reason for the growth in revenue from last year is that the devices have been upgraded according to the latest R&D and introducing new technology, due to which have been receiving a higher volume of orders.

- Additionally, the company has several upcoming distribution agreements in the pipeline.

- The company has been recognized for its innovation, having received the Mustafa Prize.

- There are 30 permanent employees who are involved in the business operations. Manufacturing personnel is outsourced.

Cancer Diagnostic Probe (CDP) can be used during breast cancer surgery for real-time pathology.

All hospitals that perform breast cancer surgeries will be clients.

Currently the device is being supplied to distributors.

Physical assets include inventory and office equipment.

Operating from 3 rented offices, 2 in Muscat and 1 in Tehran.

Business is both self funded and through investors.

Three stakeholders are involved, namely the owner, a Venture Capital (VC) firm, and a private marketing company.

The percentage and other details are confidential.